SCHEMBL2934441

SCHEMBL2934441

CC(C)OC(=O)N1CCC(C(=O)NN)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
GPR119 Q8TDV5 4/20 0.41
GAA P10253 2/20 0.41
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
PTPN2 P17706 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN6 P29350 1/20 0.39
ALDH1A1 P00352 1/20 0.39
HSD17B10 Q99714 1/20 0.38
HPGD P15428 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
MMP7 P09237 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2937807 0.81 GAA (0.62) SMN1; SMN2GPR119GAAALDH1A1CHRM1
SCHEMBL13617386 0.80 SMN1; SMN2 (0.54) SMN1; SMN2MEN1KMT2AGAANPC1
SCHEMBL1128301 0.80 GPR119 (0.43) GPR119MAPTNPC1RAB9AALDH1A1
SCHEMBL387756 0.80 NPC1 (0.46) SMN1; SMN2GPR119GAALMNAMAPT
SCHEMBL14009815 0.80 GAA (0.42) GPR119GAAHPGDCHRM2CHRM1
SCHEMBL315026 0.79 HPGD (0.60) SMN1; SMN2KMT2ANPC1RAB9APTPN2
Hydrochloric Acid SCHEMBL1128299 0.79 GPR119 (0.42) GPR119MAPTNPC1RAB9AALDH1A1
Hydrochloric Acid SCHEMBL1062317 0.79 GPR119 (0.42) GPR119MAPTNPC1RAB9AALDH1A1
SCHEMBL2937884 0.79 GAA (0.46) GPR119GAAALDH1A1CHRM2CHRM1
SCHEMBL28185381 0.78 MEN1 (0.46) SMN1; SMN2MEN1KMT2AGAAPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2134704-B1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-09-22 EP disclosed
US-20100120807-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2010-05-13 US disclosed
EP-2134704-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2009-12-23 EP disclosed
WO-2008109702-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2008-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120807-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 SMN1; SMN2 2800/4885MEN1 3081/4885KMT2A 3355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.